Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Incyte registers Phase 3 MAESTRA 3 trial in cyclin E1-overexpressing ovarian cancerSep 1Trial updateINCB123667Incyte Corporation